Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
See the first close-up photos of the moon from NASA's Artemis II mission - 2Instructions to Pick the Ideal SUV Size for Seniors
- 3American Airlines Flight Attendant Disappears Amid Layover in Colombia, Authorities Investigating
- 4Feeling wonder every day improves our health. Here’s how to do it.
- 5A definitive Manual for the 5 Off-road Bicycles Available
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- 2024's Savvy Home Gadgets for an Associated Way of life
- Wedding trip Objections in the US
- Exhaustive Experiences into Prudent Senior Living in the UK
- Kissing is an ‘evolutionary conundrum.’ Scientists just mapped its unexpected origins
- Oldest evidence of human fire-making discovered at site in England
- The Meaning of Breaking the Pen's Nib in Death penalties
- Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
- How did life begin on Earth? New experiments support 'RNA world' hypothesis
